AGY — Allergy Therapeutics Share News
0.000.00%
- £669.42m
- £716.72m
- £55.04m
REG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Allergy Therapeutics - Southern Fox: Form 8.3 – Allergy Therapeutics Plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG-Abbott Laboratories: Form 8.3 - Allergy Therapeutics PLC
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Allergy Therapeutics - FORM 8 (OPD) – Allergy Therapeutics plc
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Allergy Therapeutics - Project Zebra Rule 2.9 Announcement
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Takeover Panel - Disclosure Table (POTAM only)
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Allergy Therapeutics - Skin-prick testing completes in PROTECT Trial
AnnouncementREG - Takeover Panel - Disclosure Table
AnnouncementREG - Takeover Panel - Disclosure Table
Announcement